[{"Assets_0_Q1_USD":57701000000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.52,"CommonStockSharesConverted_0_Q1_shares":1307000000.0,"CommonStockSharesOutstanding_0_Q1_shares":1307000000.0,"EarningsPerShareBasic_1_Q1_USD":2.07,"EarningsPerShareDiluted_1_Q1_USD":2.05,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":2925000000.0,"NetIncomeLossConverted_1_Q1_USD":2699000000.0,"RevenuesConverted_1_Q1_USD":6505000000.0,"StockholdersEquity_0_Q1_USD":20441000000.0,"StockholdersEquityConverted_0_Q1_USD":20917000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1320000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1308000000.0,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170510"}]